348 related articles for article (PubMed ID: 11647660)
21. In response: speaking truth to historiography.
Faden R; Guttman D
Med Humanit Rev; 1997; 11(2):37-43. PubMed ID: 11645854
[No Abstract] [Full Text] [Related]
22. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
23. If only it were so: medical physics, U.S. human radiation experiments, and the Final Report of the President's Advisory Committee (ACHRE).
Martensen R
Med Humanit Rev; 1997; 11(2):21-36. PubMed ID: 11645853
[No Abstract] [Full Text] [Related]
24. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
25. A prostate researcher tested firm's product -- and sat on its board.
Burton TM
Wall St J (East Ed); 1998 Mar; ():A1, A8. PubMed ID: 11648093
[No Abstract] [Full Text] [Related]
26. All expenses paid, Doctor.
Greenberg DS
Lancet; 1990 Dec 22-29; 336(8730):1568-9. PubMed ID: 11653929
[No Abstract] [Full Text] [Related]
27. When good scientists turn bad.
Roman MB
Discover; 1988 Apr; 9(4):50-55, 57-58. PubMed ID: 11653808
[No Abstract] [Full Text] [Related]
28. Scientific misconduct: a form of white coat crime.
Kline S
J Pharm Law; 1993; 2(1):15-34. PubMed ID: 11653114
[No Abstract] [Full Text] [Related]
29. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
Siris ES; Burrell CD
IRB; 1983; 5(6):1-5. PubMed ID: 11649526
[No Abstract] [Full Text] [Related]
30. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
31. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
32. Penn researchers sued in gene therapy death: teen's parents also name ethicist as defendant.
Nelson D; Weiss R
Washington Post; 2000 Sep; ():A3. PubMed ID: 11660806
[No Abstract] [Full Text] [Related]
33. A U.S. experiment on young children ignites painful debate.
Moss M
Wall St J (East Ed); 1996 Jun; ():A1, A10. PubMed ID: 11648019
[No Abstract] [Full Text] [Related]
34. Doctor charged over growth hormone payments.
Kiernan V
New Sci; 1994 Aug; 143(1939):6. PubMed ID: 11659897
[No Abstract] [Full Text] [Related]
35. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
36. More Halcion headaches.
Cowley G
Newsweek; 1994 Mar; 123(10):50-2. PubMed ID: 11652702
[No Abstract] [Full Text] [Related]
37. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
Nightingale SL
Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
[No Abstract] [Full Text] [Related]
38. Federal agency revises rule on financial disclosure by researchers.
Maloney DM
Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
[No Abstract] [Full Text] [Related]
39. Fraud and sloppiness in science.
Schmaus W
Perspectives Prof; 1981; 1(3-4):1-4. PubMed ID: 11649374
[No Abstract] [Full Text] [Related]
40. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
